
ãã ã»ã³ãŒã¯ã³å士ïŒåœŒããæäŸãããŠã€ã«ã¹ãååšãããšãã蚌æã¯è©æ¬ºã§ããã
"ç§ãã¡ãå»åŠéšã«è¡ã£ããšãã¯ãã©ã¡ããã®åŽã«å€§ããªãéãä¹ã£ãŠãããšããäºå®ãããŸãçè§£ããŠããªãã£ããã§ãã ç§ãã¡ã¯ããŠã€ã«ã¹ãååšãããã©ããã¯éèŠã§ã¯ãªãããã çå®ãç¥ããããšæãã ãã§ãã ãããããŠã€ã«ã¹ã®ã¯ã¯ãã³ã売ã£ãŠããã®ãªãåé¡ã ããšããªãŒã»ã¡ãªããå士ã¯ä»æåãããã ã»ã³ãŒã¯ã³å士ã«ã€ã³ã¿ãã¥ãŒããéã«èªã£ãŠããã
äžçäžã®å€ãã®äž»èŠãªå»çæ©é¢ã¯ãç§åŠè
ãç 究宀ã§ãšã¯ãœãœãŒã ãæ€åºããã®ãšåãæ¹æ³ã§ããŠã€ã«ã¹ãæ€åºã§ãããšäž»åŒµããŠããããšã¯ãœãœãŒã ã¯ãçŽåŸ30ã150ããã¡ãŒãã«ã®å€§ããã§ã人éãç¥ãéãæãå°ããã¿ã€ãã®çްèå€å°èã§ãããããã¯ã现èã®å
å€ãç§»åããŠç©è³ªãéã¶å°ããªç©è³ªã§ããã
ããšããœãœãŒã ãçºèŠãããããšããããŸããåã倧ãããåã圢æ ãåãçš®é¡ã®éºäŒç©è³ªããŸã£ããåãããã«å«ãŸããŠããŸãããšã³ãŒã¯ã³å士ã¯ã¡ãªããå士ã«èªã£ãã
圌ã¯ããšããœãœãŒã ãšåãããã«ããŠã€ã«ã¹ææãç 人ããçŽæ¥æ¡åãã"浞挬ããéãè¶ é å¿åé¢ "ãšããããã»ã¹ãçµããšèª¬æãããç§åŠè ã¯ããã®ç©è³ªã®åœ¢æ ã瀺ããããã²ãã ãç¹åŸŽã¥ããããšãã§ããŸããããããããããŠã€ã«ã¹ã§ãã¡ããšè¡ããããšãã蚌æ ã¯å®éã«ã¯åºãŠããŠããªãã
ãã©ããªç åæ§ã®ãŠã€ã«ã¹ã§ããåã«ãããã§ããªãã ããªã®ã§ãããšåœŒã¯èšã£ãã
圌ãšååãã¡ã¯ãåœç«è¡çç ç©¶æãçŸç 管çäºé²ã»ã³ã¿ãŒãããã«ã¯ãšãŒã«å€§åŠãæŠæŒ¢ãŠã€ã«ã¹ç ç©¶æã®ãããªç ç©¶æã®å°éãŠã€ã«ã¹åŠè ãå«ãããããå Žæã®é¢ä¿è ã«ãç 人ã®äœæ¶²äžã«ãŠã€ã«ã¹ç²åãèŠããããã©ãããå°ããå€§èŠæš¡ãªèª¿æ»ãè¡ã£ãã
ãããŠã圌ãã¯ãïŒèšŒæ ãïŒãªãããšèšãã®ã§ãããšã³ãŒã¯ã³å士ã¯èšãã
圌ãšåœŒã®ååã¯ãSARS-CoV-2ã®åé¢ãšé åæ±ºå®ã«æåãããã©ãããå°éã®ãŠã€ã«ã¹åŠè ã«ãå°ããŠããã
æã ã¯ãã®äººã«å°ããã»ã»ã»ãããªããèšãCovidã«ææãã人ã®äœæ¶²ããSARS-CoV-2ãèŠã€ããããšãã§ããŸããããšåœŒã¯ããŒãšèšã£ãã[ãªããïŒèŠã€ããã«è¶³ããŠã€ã«ã¹ããªãããã ããšèšã£ãããšã³ãŒã¯ã³å士ã¯åæ³ããã
圌ã¯ããããããCovid-19ãæã€äººéããSARS-CoV-2ãŠã€ã«ã¹ãåé¢ã»ç²Ÿè£œãããã®ç¹åŸŽãæããã«ãããç§åŠè«æãå ¬éããããæ¿åºã«èŠæ±ããããäœãæç€ºãããããšã¯ãªãã£ãã
圌ã¯ããã®SARS-CoV-2ã«é¢ããããŒã¿ã®æ¬ åŠã¯ããžã«ããšãã©ãããã«ã¯HIVãšãã£ãããç¥ãããç æ°ãåŒãèµ·ããããšãããä»ã®ãŠã€ã«ã¹ãå®åšãããã©ããã«ãçåãæããããã¹ãã§ãããšèããŠããã
ãœãŒã¹ã¯ãã¡ã Covid-19ãåŒãèµ·ãããŠã€ã«ã¹ã¯å®éšå®€ã§ã¯æ±ºããŠåé¢ãããŠããªã-ãªãŒã»ã¡ãªããå士ãšãã ã»ã³ãŒã¯ã³å士ã説æã
äžã®ç»åãã¯ãªãã¯ãããšãBrighteonã§ã®ã€ã³ã¿ãã¥ãŒãã芧ããã ããŸãïŒ
ã¡ãªããã¡ãã£ã«ã«ã¢ã¯ãŒ Dr. Lee Merritt ft. ãã ã»ã³ãŒã¯ã³å士ã2022幎2æ2æ¥ïŒ49åïŒ
ããã«èªãïŒãžã£ãŒã ã»ãªãªãŒãšãŠã€ã«ã¹åŠã®åããç¬èªã®è³æã§æŽããViroLIEgyã
äŒæç
ã®ç¥è©±
ã³ãŒã¯ã³å士ã¯ãã®èæžãäŒæç ç¥è©±ãã®äžã§ããã³ãããã¯ã®ç°å¢çã黿°çãååŠçåå ã«ã€ããŠååãªæéããããŠèª¬æããŠãããé»åãæŸå°ç·ãã¬ã¹ïŒãã©ãªã¢ã®æ¬åœã®åå ã¯ã¡ã¿ã³ïŒãååŠæ¯ïŒäŸãã°ãããªãªã®æ¬åœã®åå ã¯DDTïŒããã³ãã³ã ã·ïŒå€©ç¶çã®æ¬åœã®åå ã¯ããïŒããã®ä»å€ãã®æãããªèŠå ãåå ããã以äžããæ®ºäººãŠã€ã«ã¹ãã®è©±ãäœãã ãå¿ èŠããªãããšã説åŸåããã£ãŠç€ºããŠããŸãã
èŠããã«ãèè ãèšãããã®ã¯ããããããäŒæç ãã¯ãå®ã¯ããå°åã®å ±åäœãããã¯é壿¯æ®ºã«ãã£ãŠèª¬æã§ãããšããããšã§ãã--ã€ãŸãã誰ãããã®ç æ°ãåŒãèµ·ããã®ãšåãæ¯æ§ïŒæ¬ ä¹çã«ãããããããšã«ãã£ãŠãã§ãããããåå ïŒåãå°åã«äœã人ã ãææ¯ãªé»ç£å Žãææ¯ã¬ã¹ãææ¯ååŠç©è³ªã«ãããããããããã¯äžè¡çãªç°å¢ã«çœ®ãããïŒãçºçãããšã誰ããåããããªçç¶ãæã€ç æ°ãçºçããã®ã§ããå°ãªããšãç²åããŠã€ã«ã¹ã®ãããªç©ççãªã¬ãã«ã§ã¯ã誰ããäœãããæž¡ãããæãŸãããå¿ èŠã¯ãªãã
倩ç¶çã¯å»åŠçãããã¬ã³ãã ã£ãã®ãïŒ
倩ç¶çã¯éåžžã«ææåã匷ããç¡å·®å¥ã«ææããæ»ã«è³ããŠã€ã«ã¹ã§ãããäžçäžã§äœçŸäžäººãã®æ»è ãåºãããã®æ²æšãªè¢«å®³ããæãããã®ã¯äºé²æ¥çš®ã®éçºã«ãããã®ã ãšãç§ãã¡ã¯äœäžä»£ã«ãããã£ãŠä¿¡ãããã§ãããããããäžè¬ã«å®èª¬ãšãããŠããããšã¯ãè¿ä»£å»åŠã®ãããã¬ã³ãã®çµæãããããªããã¯ã¯ãã³ã倩ç¶çãæ²æ» ããã®ã§ã¯ãªãããããåé¡ãæªåããããšããå¥ã®ã¹ããŒãªãŒãããã®ã ã
å ç«åŠã®ç¶ããšåŒã°ãããšãã¯ãŒãã»ãžã§ã³ããŒã¯ãå°å ã®èŸ²å€«ãççã®åæ³æ¶²ãèªåã«æ¥çš®ããŠå€©ç¶çã®å ç«ãç²åŸããããããšãã話ãèããŠãçã䜿ã£ãå®éšãå§ããã
ãžã§ã³ããŒã¯ç¡è©Šéšã§ã20幎åŸã«ã»ã³ãã»ã¢ã³ããªã¥ãŒã¹å€§åŠãã15ãã³ãã®å»åŠå£«å·ãååŸããã圌ã¯ãéèŠãªæ å ±ãçããèªãã®ç ç©¶ææãéé£ããéœåã®è¯ãæã ãããã䞻匵ãããèªå·±æ¬ºçã«æºã¡ãã€ãå»è ãã§ãããšãå察掟ã¯åœŒãèæ å¿ãå°å¿è ãç¡çŸããããŠåŒ·æ¬²ãªäººç©ãšèŠãªãããããã§ãã圌ã¯èªåã®ä¿¡å¿µãæåãªãšãªãŒããã¡ã«èª¬åŸããåœäŒãã3äžãã³ãïŒçŸåšã®è²šå¹£äŸ¡å€ã§çŽ300äžåïŒã®è£å©éãåŸãŠãç ç©¶ãç¶ããããšãã§ããã
1853幎ã«å¶å®ãããã¯ã¯ãã³æ¥ç𮿳ã«ãã£ãŠãã€ã®ãªã¹ã§ã¯çåŸ3ãµææªæºã®ãã¹ãŠã®ä¹³å¹Œå ã«ã¯ã¯ãã³æ¥çš®ã矩åã¥ããããããã以åã¯ããã®ç æ°ã«ãã2幎éã®æ»äº¡çã¯2,000人ã ã£ããã18幎åŸã®1871幎ã®å€§æµè¡æã«ã¯ã44,800人ã«éããŠãããçºç ãã人ã®90ïŒ ãã¯ã¯ãã³æ¥çš®ãåããŠãããšæšå®ãããã
ã¯ã¯ãã³æ¥çš®ãžã®å察ã¯ãäºæ ã奜転ããã©ãããæªåããã«ã€ãããŸããŸã匷ããªã£ãŠãã£ããã¯ã¯ãã³ã¯å®å šã§ã¯ãªãã蚌æããããŠããªããšå¿é ãã人ãå šåœã«å€§å¢ãããäºé²æ¥çš®ãæåŠãã芪ã¯çœ°éãç§ãããããååæã«å ¥ããããããããã圌ãã®æ±ºæã¯æºããããšã¯ãªãã£ãããããã圌ãã®æ±ºæã¯æºããããšã¯ãªããç²ã匷ããç©æ¥µçãªå察éåã«ãã£ãŠã1898幎ãåœäŒã¯çœ°åããªããã芪ãåã©ãã«ã¯ã¯ãã³ãæ¥çš®ãããã©ãããéžæã§ããããã«ããæ³åŸã坿±ºããã
倩ç¶çã®æ¬åœã®åé¡ã¯ãäžæœãšäžè¡çã«ãããšãšããŠã£ã³ã»ãã£ããŠã£ãã¯å¿ã¯èããã
ãŽã£ãŽã£ã¢ã³ã»ãŽã¡ãŒãžãã¢ã»ãŽã§ãã©ãŒãå士ã¯ããã®åãå ãã倩ç¶çã«é¢ãããšãã»ã€ã®äžã§ã次ã®ããã«æžããŠããã
ãããã倩ç¶çã®åæã«è¡ççãªé æ ®ããªãããŠãããªãã°ãå䜵çãèµ·ããªãã£ãã§ãããããæ¬ç©ã®è¿ç±ãã§ããããšãçšã§ãã£ããããã
åœæã®æ£è ã¯ãæããéšå±ã§ãæ±ããæ¯åžããããããçªãéãããããããã«å¯ããããŠãããçœè¡çã¯ç Žå£ãããè¿ã¯å€ã«åºããããæ¯æ§ãå¢ããå¿ ç¶çã«äºåºŠç®ã®çºç±ãèµ·ãã£ãã
å»çä»å ¥ã¯ç æ°ãæ ¹çµ¶ããã©ãããããããç æ°ãæªåãããããã ã
åºå
ž 倩ç¶çãã¯ã¯ãã³ã®ç¥è©±ïŒ

